Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 6Colitis, Ulcerative 3Spondylitis, Ankylosing 1Recurrence 1Prostatic Neoplasms 1Lymphoma 1Inflammatory Bowel Diseases 1Infections 1Diabetes Mellitus, Type 1 1Crohn Disease 1

Interventions

Adalimumab 6Etanercept 3Anti-Inflammatory Agents, Non-Steroidal 2tocilizumab 1secukinumab 1golimumab 1Vaccines 1Tumor Necrosis Factors 1Tai Ji 1Sulfasalazine 1Standard of Care 1Sodium Chloride 1Saline Solution 1Practice Guidelines as Topic 1Pamidronate 1Methods 1Meloxicam 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Exercise 1Etoricoxib 1Educational Status 1Early Intervention, Educational 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spondylitis, Ankylosing × golimumab × Clear all
NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡